Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' King, FD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bromidge, SM; Griffith, K; Heightman, TD; Jennings, A; King, FD; Moss, SF; Newman, H; Riley, G; Routledge, C; Serafinowska, HT; Thomas, DR
      Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT6 receptor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    2. Bromidge, SM; Clarke, SE; Gager, T; Griffith, K; Jeffrey, P; Jennings, AJ; Joiner, GF; King, FD; Lovell, PJ; Moss, SF; Newman, H; Riley, G; Rogers, D; Routledge, C; Serafinowska, H; Smith, DR
      Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Bromidge, SM; Dabbs, S; Davies, S; Duckworth, DM; Forbes, IT; Jones, GE; Jones, J; King, FD; Saunders, DV; Blackburn, TP; Holland, V; Kennett, GA; Lightowler, S; Middlemiss, DN; Riley, GJ; Trail, B; Wood, MD
      1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Bromidge, SM; Davies, S; Duckworth, DM; Forbes, IT; Jones, GE; Jones, J; King, FD; Blackburn, TP; Holland, V; Kennett, GA; Lightowler, S; Middlemiss, DN; Riley, GJ; Trail, B; Wood, MD
      1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    5. Bromidge, SM; Dabbs, S; Davies, DT; Davies, S; Duckworth, DM; Forbes, IT; Gaster, LM; Ham, P; Jones, GE; King, FD; Mulholland, KR; Saunders, DV; Wyman, PA; Blaney, FE; Clarke, SE; Blackburn, TP; Holland, V; Kennett, GA; Lightowler, S; Middlemiss, DN; Trail, B; Riley, GJ; Wood, MD
      Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent

      JOURNAL OF MEDICINAL CHEMISTRY
    6. Lovell, PJ; Bromidge, SM; Dabbs, S; Duckworth, DM; Forbes, IT; Jennings, AJ; King, FD; Middlemiss, DN; Rahman, SK; Saunders, DV; Collin, LL; Hagan, JJ; Riley, GJ; Thomas, DR
      A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

      JOURNAL OF MEDICINAL CHEMISTRY
    7. Bromidge, SM; Dabbs, S; Davies, DT; Davies, S; Duckworth, DM; Forbes, IT; Gadre, A; Ham, P; Jones, GE; King, FD; Saunders, DV; Thewlis, KM; Vyas, D; Blackburn, TP; Holland, V; Kennett, GA; Riley, GJ; Wood, MD
      Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    8. Bromidge, SM; Brown, AM; Clarke, SE; Dodgson, K; Gager, T; Grassam, HL; Jeffrey, PM; Joiner, GF; King, FD; Middlemiss, DN; Moss, SF; Newman, H; Riley, G; Routledge, C; Wyman, P
      5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A potent, selective, and orally bioavailable 5-HT6 receptor antagonist

      JOURNAL OF MEDICINAL CHEMISTRY
    9. PARSONS AA; RAVAL P; SMITH S; TILFORD N; KING FD; KAUMANN AJ; HUNTER J
      EFFECTS OF THE NOVEL HIGH-AFFINITY 5-HT1B 1D-RECEPTOR LIGAND FROVATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES/

      Journal of cardiovascular pharmacology
    10. GASTER LM; BLANEY FE; DAVIES S; DUCKWORTH DM; HAM P; JENKINS S; JENNINGS AJ; JOINER GF; KING FD; MULHOLLAND KR; WYMAN PA; HAGAN JJ; HATCHER J; JONES BJ; MIDDLEMISS DN; PRICE GW; RILEY G; ROBERTS C; ROUTLEDGE C; SELKIRK J; SLADE PD
      THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO

      Journal of medicinal chemistry
    11. FORBES IT; DABBS S; DUCKWORTH DM; JENNINGS AJ; KING FD; LOVELL PJ; BROWN AM; COLLIN L; HAGAN JJ; MIDDLEMISS DN; RILEY GJ; THOMAS DR; UPTON N
      (4-METHYL-PIPERIDIN-1-YL)PROPYL]BENZENESULFONAMIDE - THE FIRST SELECTIVE 5-HT7 RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    12. BROMIDGE SM; DABBS S; DAVIES DT; DUCKWORTH DM; FORBES IT; HAM P; JONES GE; KING FD; SAUNDERS DV; STARR S; THEWLIS KM; WYMAN PA; BLANEY FE; NAYLOR CB; BAILEY F; BLACKBURN TP; HOLLAND V; KENNETT GA; RILEY GJ; WOOD MD
      NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/

      Journal of medicinal chemistry
    13. KING FD; WINSON P; SNIDER AD; DUNLEAVY L; LEVINSON DP
      MATH METHODS IN TRANSISTOR MODELING - CONDITION NUMBERS FOR PARAMETEREXTRACTION

      IEEE transactions on microwave theory and techniques
    14. GASTER LM; KING FD
      SEROTONIN 5-HT3 AND 5-HT4 RECEPTOR ANTAGONISTS

      Medicinal research reviews
    15. PARSONS AA; PARKER SG; RAVAL P; CAMPBELL CA; LEWIS VA; GRIFFITHS R; HUNTER AJ; HAMILTON TC; KING FD
      COMPARISON OF THE CARDIOVASCULAR EFFECTS OF THE NOVEL 5-HT1B 1D RECEPTOR AGONIST, SB-209509 (VML251), AND SUMATRIPTAN IN DOGS/

      Journal of cardiovascular pharmacology
    16. BROMIDGE SM; DUCKWORTH M; FORBES IT; HAM P; KING FD; THEWLIS KM; BLANEY FE; NAYLOR CB; BLACKBURN TP; KENNETT GA; WOOD MD; CLARKE SE
      ETHYL-3-PYRIDYL)OXY]-5-PYRIDYL]CARBAMOYL]-INDOLINE (SB-242084) - THE FIRST SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    17. FORBES IT; DABBS S; DUCKWORTH DM; HAM P; JONES GE; KING FD; SAUNDERS DV; BLANEY FE; NAYLOR CB; BAXTER GS; BLACKBURN TP; KENNETT GA; WOOD MD
      SYNTHESIS, BIOLOGICAL-ACTIVITY, AND MOLECULAR MODELING STUDIES OF SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS/

      Journal of medicinal chemistry
    18. PARSONS AA; PARKER SG; RAVAL P; CAMPBELL CA; HUNTER AJ; HAMILTON TC; KING FD
      COMPARISON OF THE CARDIOVASCULAR EFFECTS OF SB-209509 (VML-251) AND SUMATRIPTAN IN DOGS

      British Journal of Pharmacology
    19. BROWN AM; PARSONS AA; RAVAL P; PORTER R; TILFORD NS; GAGER TL; PRICE GW; WOOD MD; KAUMANN AJ; YOUNG RA; RANA K; WARRINGTON BH; KING FD
      SB-209509 (VML-251), A POTENT CONSTRICTOR OF RABBIT BASILAR ARTERY WITH HIGH-AFFINITY AND SELECTIVITY FOR HUMAN 5-HT1D RECEPTORS

      British Journal of Pharmacology
    20. RAVAL P; TILFORD NS; SMITH SJ; PORTER R; KING FD; KAUMANN AJ; HUNER AJ; PARSONS AA
      A COMPARISON OF THE AGONIST PROFILE OF SB-209509 (VML-251) AND SUMATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES

      British Journal of Pharmacology
    21. COLDWELL MC; GADRE A; JERMAN J; KING FD; NASH D
      THE SYNTHESIS, AND DOPAMINE D-2 AND SEROTONIN 5-HT3 RECEPTOR AFFINITYOF 3-AZA ANALOGS (PYRIDYL) OF 4-AMINO-5-CHLORO-2-METHOXYBENZAMIDES

      Bioorganic & medicinal chemistry letters
    22. GREGORY JA; JENNINGS AJ; JOINER GF; KING FD; RAHMAN SK
      SYNTHESIS OF (ENDO) 3,9-DISUBSTITUTED DIAZABICYCLO[3.3.1]NONAN-7-AMINES

      Tetrahedron letters
    23. GASTER LM; JOINER GF; KING FD; WYMAN PA; SUTTON JM; BINGHAM S; ELLIS ES; SANGER GJ; WARDLE KA
      IHYDRO-2H-[1,3]OXAZINO[3,2-A]INDOLE-10-CARBOXAMIDE HYDROCHLORIDE - THE FIRST POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST AMIDE WITH ORALACTIVITY

      Journal of medicinal chemistry
    24. BERMUDEZ J; GASTER L; GREGORY J; JERMAN J; JOINER GF; KING FD; RAHMAN SK
      SYNTHESIS AND 5-HT3 RECEPTOR ANTAGONIST POTENCY OF NOVEL (ENDO) 3,9-DIAZABICYCLO[3.3.1]NONAN-7-AMINO DERIVATIVES

      Bioorganic & medicinal chemistry letters
    25. KAUMANN AJ; GASTER LM; KING FD; BROWN AM
      BLOCKADE OF HUMAN ATRIAL 5-HT4 RECEPTORS BY SB-207710, A SELECTIVE AND HIGH-AFFINITY 5-HT4 RECEPTOR ANTAGONIST

      Naunyn-Schmiedeberg's archives of pharmacology
    26. GASTER LM; JENNINGS AJ; JOINER GF; KING FD; MULHOLLAND KR; RAHMAN SK; STARR S; WYMAN PA; WARDLE KA; ELLIS ES; SANGER GJ
      (1-BUTYL-4-PIPERIDINYL)METHYL 8-AMINO-7-CHLORO-1,4-BENZODIOXANE-5-CARBOXYLATE HYDROCHLORIDE - A HIGHLY POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST DERIVED FROM METOCLOPRAMIDE

      Journal of medicinal chemistry
    27. KING FD; BROWN AM; GASTER LM; KAUMANN AJ; MEDHURST AD; PARKER SG; PARSONS AA; PATCH TL; RAVAL P
      )3-AMINO-6-CARBOXAMIDO-1,2,3,4-TETRAHYDROCARBAZOLE - A CONFORMATIONALLY RESTRICTED ANALOG OF 5-CARBOXAMIDOTRYPTAMINE WITH SELECTIVITY FOR THE SEROTONIN 5-HT1D RECEPTOR (VOL 36, PG 1919, 1993)

      Journal of medicinal chemistry
    28. KING FD; BROWN AM; GASTER LM; KAUMANN AJ; MEDHURST AD; PARKER SG; PARSONS AA; PATCH TL; RAVAL P
      (+ -) 3-AMINO-6-CARBOXAMIDO-1,2,3,4-TETRAHYDROCARBAZOLE - A CONFORMATIONALLY RESTRICTED ANALOG OF 5-CARBOXAMIDOTRYPTAMINE WITH SELECTIVITY FOR THE SEROTONIN 5-HT1D RECEPTOR/

      Journal of medicinal chemistry
    29. CHIN TS; LIN CH; HUANG YH; YAU JM; HEH SJ; KING FD
      ENHANCED THERMAL-STABILITY OF SINTERED (ND,DY)(FE,CO)B MAGNETS BY THEADDITION OF TA OR TI

      IEEE transactions on magnetics
    30. BROWN AM; YOUNG TJ; PATCH TL; CHEUNG CW; KAUMANN AJ; GASTER L; KING FD
      [I-125] SB-207710, A POTENT, SELECTIVE RADIOLIGAND FOR 5-HT(4) RECEPTORS

      British Journal of Pharmacology
    31. WARDLE KA; ELLIS ES; GASTER LM; KING FD; SANGER GJ
      SB-204070 - A HIGHLY POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 17:29:49